Relevium Technologies Inc.

Equities

RLV.H

CA75942W1023

Food Processing

Delayed Toronto S.E. 12:24:28 2023-10-06 am EDT 5-day change 1st Jan Change
0.02 CAD -.--% Intraday chart for Relevium Technologies Inc. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Relevium Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Relevium Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Relevium Technologies Inc. Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Relevium Technologies Inc. Auditor Raises 'Going Concern' Doubt CI
Transcript : Relevium Technologies Inc. - Shareholder/Analyst Call
Relevium Provides Operational and Continued Disclosure Update MT
Relevium Provides Operational and Continued Disclosure Update MT
Relevium Technologies Inc. cancelled the acquisition of Med PPE Canada Inc. CI
Relevium Technology Brief: Over the Weekend Said It Expects To File Annual Financial Filings By January 31, 2022; Detailed Shares for Debt Settlement MT
Relevium Soars 66.7% after Reporting 2 PPE Contracts MT
Relevium to Acquire Med PPE Canada MT
Relevium Technologies Inc. entered into a nonbinding term sheet to acquire Med PPE Canada Inc. for CAD 10.4 million. CI
Relevium Technologies Brief: Overnight Monday Announced Delay in Filing Annual Financial Statements MT
Relevium Technologies Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021 CI
Relevium Technologies : Names Chief Scientific Officer for Cannabinoid Research Unit MT
Relevium Technologies : Says Contracted Delivery of Medical Examination Gloves Delayed MT
Relevium Technologies Inc. Provides Update on the Exclusive Supply of Medical Examination Gloves CI
Relevium Technologies : Subsidiary Biocannabix Enters LOI with IAM Health for Research Opportunities MT
Relevium Technologies : Soars 20% after Reporting Unit's Partnership with German R&D Company MT
Relevium Technologies Inc. and Biocannabix Health Corporation Enters in Letter of Intent with IAM Health GmbH to Pursue Number of Pre-Defined Research Opportunities CI
Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April CI
Relevium Technologies : Secures North American Exclusivity For Medical Examination Gloves MT
Earnings Flash (FRANKFURT:6BX) RELEVIUM TECHNOLOGIES Posts Q1 Loss C$0.002 MT
Relevium Technologies Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020 CI
Earnings Flash (FRANKFURT:6BX) RELEVIUM TECHNOLOGIES Posts Q4 Revenue C$0.3 Million MT
Chart Relevium Technologies Inc.
More charts
Relevium Technologies Inc. is a Canada-based company, which operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets with a focus on e-commerce. The Company operates through two wholly owned subsidiaries, BGX E-Health LLC and Biocannabix Health Corporation Inc. BGX E-Health LLC markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals, primarily through its Bioganix brand portfolio online in the United States. It provides a Push & Pull System by Bioganix. Push & Pull System is a comprehensive natural anti-aging system for complete skin care that combines collagen protein supplements (PUSH) and naturally sourced aloe vera skin anti-aging cream (PULL).
More about the company
  1. Stock Market
  2. Equities
  3. RLV.H Stock
  4. News Relevium Technologies Inc.
  5. Relevium Technologies : Secures North American Exclusivity For Medical Examination Gloves